Funder
National Cancer Institute
Breast Cancer Research Foundation
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference49 articles.
1. Bathen, T. F., Geurts, B., Sitter, B., Fjøsne, H. E., Lundgren, S., Buydens, L. M., et al. (2013). Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS ONE, 8(4), e61578.
2. Bathen, T. F., Jensen, L. R., Sitter, B., Fjösne, H. E., Halgunset, J., Axelson, D. E., et al. (2007). MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Research and Treatment, 104(2), 181–189.
3. Bathen, T. F., Sitter, B., Sjobakk, T. E., Tessem, M.-B., & Gribbestad, I. S. (2010). Magnetic resonance metabolomics of intact tissue: A biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Research, 70(17), 6692–6696.
4. Bitencourt, A. G. V., Pinker, K., & Thakur, S. (2019). Elevated glycine detected on in vivo magnetic resonance spectroscopy in a breast cancer patient: Case report and literature review. BJR Case Reports, 5, 20190090.
5. Borgan, E., Sitter, B., Lingjærde, O. C., Johnsen, H., Lundgren, S., Bathen, T. F., et al. (2010). Merging transcriptomics and metabolomics: Advances in breast cancer profiling. BMC Cancer, 10(1), 628.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献